Pharmacologic dilation changes the examination conditions by enlarging the pupil before the clinician views the fundus. This can facilitate inspection with an ophthalmoscope or slit-lamp biomicroscope, which provide illumination and magnification. The resulting view supports assessment of the macula, optic disc, and retinal blood vessels for structural abnormalities.
Retinal findings can reflect both local ocular damage and changes associated with systemic disease. In particular, clinicians may evaluate retinal blood vessels alongside the macula and optic disc, because abnormalities in these structures can contribute to recognizing diabetic retinopathy, vascular changes, or optic nerve damage. This broader information supports diagnosis and clinical monitoring.
The two instruments are relevant because they provide illumination and magnification for viewing the fundus. Using either approach, clinicians can inspect the macula, optic disc, and retinal blood vessels for structural abnormalities. This shared capability makes them useful for evaluating ocular health and for recognizing findings that may warrant diagnosis, monitoring, or referral.
The macula, optic disc, and retinal blood vessels receive particular attention because each can reveal clinically important abnormalities. Evaluation may identify changes associated with diabetic retinopathy, retinal detachment, vascular changes, or optic nerve damage. Considering these structures together helps clinicians assess ocular health, recognize possible systemic disease, and determine whether monitoring or referral is needed.
Before viewing the fundus, clinicians may use pharmacologic dilation. They then examine the illuminated and magnified view with an ophthalmoscope or slit-lamp biomicroscope, focusing on the macula, optic disc, and retinal blood vessels. If abnormalities are identified, the findings can support diagnosis, ongoing monitoring, timely treatment, or referral.
Fundus photography and optical coherence tomography add a record that can be compared across visits. Their main contribution is documentation of retinal changes over time, complementing the clinician’s direct assessment. This longitudinal record can support monitoring, help show whether findings change, and inform decisions about continued care or referral.